Consequently, we postulate that Nurr1 may wield regulatory control over NLRP3 expression, thereby influencing the activation of the NLRP3 inflammasome within the inflammatory context of PD, via a transcription factor-miRNA regulatory pathway. The gene discussed is NR4A2; the disease is Parkinson disease.